ArticleBone marrow transplantation2023

Venetoclax-based therapy as a bridge to allogeneic hematopoietic cell transplantation in children with relapsed/refractory AML.

Thomas Pfeiffer et al.PubMed ↗Publisher ↗

No numbers read from the abstract.